Patents by Inventor Anton J. Hopfinger

Anton J. Hopfinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030101003
    Abstract: The invention includes methods of representing polymer sequences in a way that reveals important position-specific contextual information. The representations can be used to determine a number of properties of polymers, such as protein and nucleic acid sequences, including the identification of secondary domain structures, folding rate constants, and the effects of altering (e.g., mutating) monomers. In addition, the representations can be used to compare polymers and thereby identify important structural and functional characteristics of polymers.
    Type: Application
    Filed: June 21, 2002
    Publication date: May 29, 2003
    Inventors: Albert S. Benight, Petr Pancoska, Anton J. Hopfinger, Peter V. Riccelli
  • Publication number: 20030077607
    Abstract: The present invention provides methods and means for analyzing, designing, selecting and generating oligomer sequences, such as those for use in multiplex array-based nucleic acid probe systems, down to the selection of a single pair of optimal primer/target oligomers. Sequences are represented by a function of sequence context, called the context functional descriptor. In addition to the consideration of base pairing and nearest-neighbor analysis, the present computational methods incorporate the use of context functional descriptors and correlation matrices to account for higher-order thermodynamic interactions between nucleic acid sequences.
    Type: Application
    Filed: March 11, 2002
    Publication date: April 24, 2003
    Inventors: Anton J. Hopfinger, Peter V. Riccelli, Petr Pancoska, Albert S. Benight
  • Publication number: 20020169561
    Abstract: The methods of the invention allow for the construction and/or use of modular computational models to accurately predict the therapeutic properties, including both therapeutic potency and one or more ADMET properties, of all or part of a chemical compound. The modular computational models can be used to rapidly screen libraries of chemical compounds, and reliably identify small subsets of those chemical compounds that have desirable therapeutic potency and ADMET properties, and are thus the best overall drug candidates.
    Type: Application
    Filed: January 28, 2002
    Publication date: November 14, 2002
    Inventors: Albert S. Benight, Peter V. Riccelli, Anton J. Hopfinger, Petr Pancoska
  • Patent number: 5814460
    Abstract: The invention allows the generation and screening of a large population of peptides for the presence of peptides which bind a particular macromolecule or macromolecular complex with high affinity, and further allows the favored net synthesis of analyzable quantities of such peptides, by using is the "trap" a macromolecule or macromolecular complex for which binding of the peptide is desired. The starting mixture is preferably spiked with a peptide having some affinity for the target macromolecule so that mutation of the spike or "lead" peptide is favored. The development of improved binding peptides through scrambling may be dynamically monitored by initially binding the target with an insolubilized ligand, and then looking for an increase in the concentration of the target in the soluble phase as a result of the displacement of the reference ligand by scrambled peptides.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: September 29, 1998
    Assignee: Diatide, Inc.
    Inventors: Duane L. Venton, Anton J. Hopfinger, Guy Lebreton
  • Patent number: 5366862
    Abstract: The invention allows the generation and screening of a large population of peptides for the presence of peptides which bind a particular macromolecule or macromolecular complex with high affinity, and further allows the favored net synthesis of analyzable quantities of such peptides, by using as the "trap" a macromolecule or macromolecular complex for which binding of the peptide is desired. The starting mixture is preferably spiked with a peptide having some affinity for the target macromolecule so that mutation of the spike or "lead" peptide is favored. The development of improved binding peptides through scrambling may be dynamically monitored by initially binding the target with an insolubilized ligand, and then looking for an increase in the concentration of the target in the soluble phase as a result of the displacement of the reference ligand by scrambled peptides.
    Type: Grant
    Filed: August 21, 1992
    Date of Patent: November 22, 1994
    Assignee: Receptor Laboratories, Inc.
    Inventors: Duane L. Venton, Anton J. Hopfinger, Guy Le Breton